Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | ABSL |
| NAV | ₹40.2296 | ₹49.3781 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 10.9 years | 13.9 years |
| Expense ratio | 1.1% | 2.0% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 68.00 | 66.60 |
Returns
| Tata India Pharma & Healthcare Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| 1 month | +9.87% | −12.41% |
| 3 months | +1.12% | −13.90% |
| 6 months | +7.63% | −13.22% |
| YTD | +13.73% | −2.12% |
| 1 year | +11.82% | +4.39% |
| 3 years (CAGR) | +18.74% | +15.21% |
| 5 years (CAGR) | +16.00% | +8.81% |
| 10 years (CAGR) | +15.95% | +11.74% |
| Since launch | +13.58% | +10.78% |
Risk
| Tata India Pharma & Healthcare Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Volatility | 15.7% | 14.1% |
| Downside volatility | 10.0% | 9.2% |
| Sharpe | 0.78 | 0.62 |
| Sortino | 1.23 | 0.94 |
| Calmar | 1.12 | 0.95 |
| Return / risk | 1.19 | 1.08 |
| Deepest fall | −19.84% | −27.46% |
| Days to recover | 375 | 77 |
| Below its high | +0.00% | −15.93% |
Against benchmark
| Tata India Pharma & Healthcare Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Alpha | −2.99% | +8.47% |
| Beta | 1.00 | 0.04 |
| R² | 90.2% | 0.2% |
| Up capture | 91.3% | 40.6% |
| Down capture | 102.0% | −21.1% |
| Tracking error | 4.9% | 21.0% |
| Information ratio | −0.62 | 0.14 |
| Treynor | 0.11 | 2.38 |
Consistency
| Tata India Pharma & Healthcare Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Best 1-year | +76.35% | +57.49% |
| Middle 1-year | +8.85% | +11.36% |
| Worst 1-year | −17.32% | −15.10% |
| 1-year periods with a loss | 29.0% | 15.1% |
| Middle 3-year | +21.13% | +10.25% |
| Positive months | 63.9% | 66.7% |
| Best day | +3.34% | +2.91% |
| Worst day | −3.09% | −4.85% |
| Worst 5% day | −1.35% | −1.21% |
| Positive days | 55.4% | 57.5% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| 5-year XIRR | +18.07% | +11.37% |
| 5-year value | ₹9,50,065 | ₹8,02,992 |
| 3-year XIRR | +13.31% | +10.54% |
| 1-year XIRR | +18.41% | −12.95% |
Holdings overlap i
Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
- Tata India Pharma & Healthcare Fund: no monthly portfolio filing from Tata is loaded yet, so it is left out here.
- Aditya Birla Sun Life International Equity Fund: no monthly portfolio filing from ABSL is loaded yet, so it is left out here.